CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion, in another indication of the ...

Australia’s largest health company has suffered a $10.3 billion blow after warning of a lower profit and downgrading the ...

Should I invest $10,000 in CSL Ltd (ASX: CSL) shares before the end of May? Here’s why I’d consider it after the selloff.

The global biotechnology company will brief analysts on its latest downgrade on Monday morning after a horror year for the ...

CSL Limited's Transformation Program targets $500–$550M in annual pre-tax cost reductions by FY28. Read why CSLLY stock is a ...

CSL (ASX: CSL) shares plunged sharply on Monday after the Australian biopharmaceutical giant downgraded its fiscal 2026 ...

Following CSL’s second-largest one-day fall on record following an earnings downgrade, fresh questions have emerged over ...

Learn More Over the years, CSL Ltd (ASX: CSL) shares have rarely been on the radar of income investors. That's not because ...

Having flagged modest revenue and earnings growth for the full year, CSL now has warned it will go backwards on both metrics.

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...